Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

XBiotech

PUBLIC STATUS
51-60 EMPLOYEES
XBIT STOCK SYMBOL
$8.22 SHARE PRICE (As of Friday Closing)
Description

XBiotech Inc is an US based clinical-stage biopharmaceutical company which is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing MABp1 a therapeutic antibody as a treatment for cancer. It has developed therapeutic antibody Xilonix which is being evaluated as a monotherapy to treat advanced stages of colorectal cancer. Xilonix neutralizes a pro-inflammatory protein produced by leukocytes and other cells.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 8201 E Riverside Drive
  • Building 4 Suite 100
  • Austin, TX 78744
  • United States

+1 (512) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore XBiotech’s full profile, request a free trial.

XBiotech Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.13 - $11.74 $337M $8.60 -$0.63 197K 41M

XBiotech Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 298,470 161,115 100,648 281,740
Revenue 0 0 0 0
EBITDA (20,803) (19,105) (32,020) (52,112)
Net Income (22,878) (21,138) (33,150) (52,761)
Total Assets 71,875 44,345 62,972 67,050
Public Fundamental Data provided by Morningstar, Inc. disclaimer

XBiotech Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore XBiotech‘s full profile, request access.

Request full access to PitchBook

XBiotech Competitors (79)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BeiGene Formerly PE-Backed Beijing, China 0000 00.000 00000000 00.000
000000000 00000000 Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
000 000000000000 Venture Capital-Backed Epalinges, Switzerland 00 00000 00000000000 00000
0000000 0000000000 Corporation San Diego, CA 00 00000 000000000 00000
00000 Venture Capital-Backed Cambridge, United Kingdom 000 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

XBiotech Executive Team (1)

Name Title Board
Seat
Contact
Info
John Simard Chief Executive Officer & Chairman

XBiotech Board Members (1)

Name Representing Role Since Contact
Info
0000 000000 XBiotech Chief Executive Officer & Chairman 000 0000